Kroger, Albertsons and others allege an unlawful monopoly in one legal case and aim to recover overcharges for a drug in ...

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

The Trump administration said in mid-April to expect tariffs on drug imports in a month or so, which puts the deadline ...

Chief executives at the largest drugmakers in the world are confident tariffs and pricing measures won’t be a major problem.

When David Ricks became CEO of Eli Lilly, he faced the usual pressures of making the right, albeit risky, bets on the next ...

Big Pharmas aren’t letting the looming threat of potential tariffs divert them from their M&A strategies for the year—at ...

Ironwood Pharmaceuticals shares dropped 14.6% on Wednesday after the company reported a steep revenue miss in the first ...

New Jersey-based pharmaceutical giant Merck is investing $1 billion in what company executives described as a continued ...

A bipartisan group of congressional lawmakers introduced a bill Monday to eliminate a tax deduction pharmaceutical companies ...

The pharma stocks in India see significant selloff after US President Donald Trump signs executive orders promoting active ...